File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effects of a transitional palliative care model on patients with end-stage heart failure: Study protocol for a randomized controlled trial

TitleEffects of a transitional palliative care model on patients with end-stage heart failure: Study protocol for a randomized controlled trial
Authors
KeywordsTransitional care
End-stage heart failure
Palliative care
Health services utilization
Quality of life
Issue Date2016
Citation
Trials, 2016, v. 17, n. 1, article no. 173 How to Cite?
Abstract© 2016 Ng et al. Background: Heart failure (HF) is characterized by high rates of readmission after hospitalization, and readmission is a major contributor to healthcare costs. The transitional care model has proven efficacy in reducing the readmission rate and economic outcomes, and increasing satisfaction with care. However, the effectiveness of the transitional care model has not been evaluated in patients with end-stage HF. This study was designed to compare the customary hospital-based care and a comprehensive transitional care model, namely the Home-based Palliative HF Program (HPHP), in terms of readmission rate, quality of life, and satisfaction with care among end-stage HF patients under palliative care. Methods/design: This is a randomized controlled trial taking place in hospitals in Hong Kong. We have been recruiting patients with end-stage HF who are identified as appropriate for palliative care during hospitalization, on referral by their physicians. A set of questionnaires is collected from each participant upon discharge. Participants are randomized to receive usual care (customary hospital-based care) or the intervention (HPHP). The HPHP will be implemented for up to 12 months. Outcome measures will be performed at 1, 3, 6, and 12 months post-discharge. The primary outcome of this study is quality of life measured by the Chronic Heart Failure Questionnaire - Chinese version; secondary outcomes include readmission rate, symptom intensity, functional status, and satisfaction with care. Discussion: This study is original and will provide important information for service development in the area of palliative care. The introduction of palliative care to end-stage organ failure patients is new and has received increasing attention worldwide in the last decade. This study adopts the randomized controlled trial, a vigorous research design, to establish scientific evidence in exploring the best model for end-stage HF patients receiving palliative care.
Persistent Identifierhttp://hdl.handle.net/10722/277662
ISSN
2023 Impact Factor: 2.0
2023 SCImago Journal Rankings: 0.812
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorNg, Alina Yee Man-
dc.contributor.authorWong, Frances Kam Yuet-
dc.contributor.authorLee, Paul Hong-
dc.date.accessioned2019-09-27T08:29:38Z-
dc.date.available2019-09-27T08:29:38Z-
dc.date.issued2016-
dc.identifier.citationTrials, 2016, v. 17, n. 1, article no. 173-
dc.identifier.issn1745-6215-
dc.identifier.urihttp://hdl.handle.net/10722/277662-
dc.description.abstract© 2016 Ng et al. Background: Heart failure (HF) is characterized by high rates of readmission after hospitalization, and readmission is a major contributor to healthcare costs. The transitional care model has proven efficacy in reducing the readmission rate and economic outcomes, and increasing satisfaction with care. However, the effectiveness of the transitional care model has not been evaluated in patients with end-stage HF. This study was designed to compare the customary hospital-based care and a comprehensive transitional care model, namely the Home-based Palliative HF Program (HPHP), in terms of readmission rate, quality of life, and satisfaction with care among end-stage HF patients under palliative care. Methods/design: This is a randomized controlled trial taking place in hospitals in Hong Kong. We have been recruiting patients with end-stage HF who are identified as appropriate for palliative care during hospitalization, on referral by their physicians. A set of questionnaires is collected from each participant upon discharge. Participants are randomized to receive usual care (customary hospital-based care) or the intervention (HPHP). The HPHP will be implemented for up to 12 months. Outcome measures will be performed at 1, 3, 6, and 12 months post-discharge. The primary outcome of this study is quality of life measured by the Chronic Heart Failure Questionnaire - Chinese version; secondary outcomes include readmission rate, symptom intensity, functional status, and satisfaction with care. Discussion: This study is original and will provide important information for service development in the area of palliative care. The introduction of palliative care to end-stage organ failure patients is new and has received increasing attention worldwide in the last decade. This study adopts the randomized controlled trial, a vigorous research design, to establish scientific evidence in exploring the best model for end-stage HF patients receiving palliative care.-
dc.languageeng-
dc.relation.ispartofTrials-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectTransitional care-
dc.subjectEnd-stage heart failure-
dc.subjectPalliative care-
dc.subjectHealth services utilization-
dc.subjectQuality of life-
dc.titleEffects of a transitional palliative care model on patients with end-stage heart failure: Study protocol for a randomized controlled trial-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/S13063-016-1303-7-
dc.identifier.pmid27037096-
dc.identifier.pmcidPMC4815195-
dc.identifier.scopuseid_2-s2.0-85007417851-
dc.identifier.volume17-
dc.identifier.issue1-
dc.identifier.spagearticle no. 173-
dc.identifier.epagearticle no. 173-
dc.identifier.isiWOS:000373487300005-
dc.identifier.issnl1745-6215-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats